Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-11

FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (NOVITIUM PHARMA)

View source ↗

Summary

Supplemental approval for a combination product containing glipizide and metformin hydrochloride by Novitium Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide and Metformin Hydrochloride (glipizide and metformin hydrochloride)

Snippet

SUPPL AP for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE)